Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update indicates a Phase 1/2 study of BHB810 in advanced gastric and GEJ adenocarcinoma, with the trial currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Safety and Efficacy of Trastuzumab BS
Pfizer's trastuzumab biosimilar (Trastuzumab BS) in gastric cancer has completed the trial. Results were posted on 2026-04-14, assessing saf…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT) [Phase 2]
Phase 2 perioperative trial evaluating Spartalizumab with the FLOT chemotherapy regimen for resectable gastric cancer; results were posted o…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy [Phase 2, Phase 3]
A Phase 2/3 trial comparing ramucirumab plus FOLFIRI versus ramucirumab plus paclitaxel in patients with advanced or metastatic gastric/EGJ …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: 18F-FDG PET/CT in Gastric Cancer
A clinical trial evaluating 18F-FDG PET/CT in gastric cancer has completed. The study was sponsored by Sohag University.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
A clinical trial investigating molecular and epidemiological risk factors for gastric cancer has been terminated.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]
A Phase Ib/II clinical trial evaluating ATG-022 in combination with pembrolizumab, with or without chemotherapy, for CLDN18.2-positive, HER2…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 [Phase 3]
Phase 3 trial evaluating Sonesitatug Vedotin with Capecitabine, with or without Rilvegostomig, in advanced or metastatic Claudin18.2-express…
-
CLINICAL_TRIALS label_change · 2026-04-13Clinical Trial Update: Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the combination of trastuzumab deruxtecan (DS-8201a) and azenosertib (ZN-c3) in gastric and gastroesophage…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management
This clinical trial update analyzes the costs of opportunistic upper gastrointestinal endoscopy and the economic burden of managing gastric …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer
Clinical trial update on an AI-assisted approach to guide decision-making for reoperation in patients experiencing postoperative bleeding af…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanc…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Vanguard Study: Testing a New Way to Screen for Cancer [NA]
The Vanguard Study is a National Cancer Institute–sponsored cancer screening trial that is currently recruiting to evaluate a new screening …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers [Phase 1]
Clinical trial update indicating Janssen's investigational asset JNJ-89402638 is in Phase 1 testing for metastatic colorectal and gastric ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan [Phase 1]
Phase 1 trial evaluating the safety, adverse events, and pharmacokinetics of Azirkitug alone or in combination with Budigalimab, Bevacizumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations [Phase 2]
This clinical trial update describes a Phase 2 study evaluating talazoparib in patients with advanced cancers and DNA repair variations, and…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer [Phase 3]
A Phase 3 clinical trial evaluating Adebrelimab as perioperative therapy for locally advanced gastric or gastroesophageal junction cancer is…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]
IAM1363 is being studied in a Phase 1/1b trial for HER2-related cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer [Phase 2, Phase 3]
Pfizer is enrolling patients in a Phase 2/Phase 3 study testing PF-08634404 with chemotherapy for untreated advanced or metastatic gastric c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]
This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers underg…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer [Phase 3]
This Phase 3 trial is evaluating rilvegostomig in combination with a fluoropyrimidine and trastuzumab deruxtecan as first-line therapy for H…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective)
A prospective clinical trial evaluating DeepComp for predicting postoperative complications in gastric cancer, currently recruiting.